62 related articles for article (PubMed ID: 36362498)
1. Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease.
Li B; Wang Y; Jiang X; Du H; Shi Y; Xiu M; Liu Y; He J
Biomed Pharmacother; 2023 Aug; 164():114950. PubMed ID: 37263167
[TBL] [Abstract][Full Text] [Related]
2. Large-Scale Identification of Lysine Crotonylation Reveals Its Potential Role in Oral Squamous Cell Carcinoma.
Yin X; Zhang H; Wei Z; Wang Y; Han S; Zhou M; Xu W; Han W
Cancer Manag Res; 2023; 15():1165-1179. PubMed ID: 37868687
[TBL] [Abstract][Full Text] [Related]
3. Maggot extracts chemo-prevent inflammation and tumorigenesis accompanied by changes in the intestinal microbiome and metabolome in AOM/DSS-induced mice.
Tang X; Wang L; Wang D; Zhang Y; Wang T; Zhu Z; Weng Y; Tao G; Wang Q; Tang L; Yan F; Wang Y
Front Microbiol; 2023; 14():1143463. PubMed ID: 37200915
[TBL] [Abstract][Full Text] [Related]
4. Maggot Extract Inhibits Cell Migration and Tumor Growth by Targeting HSP90AB1 in Ovarian Cancer.
Wang D; Wang R; Cai M; Zhang Y; Zhu Z; Weng Y; Wang L; Huang Y; Du R; Wu X; Tao G; Wang Y
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362498
[TBL] [Abstract][Full Text] [Related]
5. HSP90AB1 as the Druggable Target of Maggot Extract Reverses Cisplatin Resistance in Ovarian Cancer.
Wang D; Tang X; Ruan J; Zhu Z; Wang R; Weng Y; Zhang Y; Wang T; Huang Y; Wang H; Su Z; Wu X; Tao G; Wang Y
Oxid Med Cell Longev; 2023; 2023():9335440. PubMed ID: 37180757
[TBL] [Abstract][Full Text] [Related]
6. HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma.
Zhang H; Yin X; Zhang X; Zhou M; Xu W; Wei Z; Song C; Han S; Han W
Technol Cancer Res Treat; 2022; 21():15330338221118202. PubMed ID: 35929142
[No Abstract] [Full Text] [Related]
7. HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response.
Liu X; Yu Y; Zhang J; Lu C; Wang L; Liu P; Song H
Cell Physiol Biochem; 2018; 48(4):1505-1518. PubMed ID: 30071534
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
[TBL] [Abstract][Full Text] [Related]
9. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
Wang DY; Li N; Cui YL
Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
[TBL] [Abstract][Full Text] [Related]
10. Potential clinical utility of liquid biopsies in ovarian cancer.
Zhu JW; Charkhchi P; Akbari MR
Mol Cancer; 2022 May; 21(1):114. PubMed ID: 35545786
[TBL] [Abstract][Full Text] [Related]
11. CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype.
Li H; Luo F; Jiang X; Zhang W; Xiang T; Pan Q; Cai L; Zhao J; Weng D; Li Y; Dai Y; Sun F; Yang C; Huang Y; Yang J; Tang Y; Han Y; He M; Zhang Y; Song L; Xia JC
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35277458
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
